Vildagliptin/Metformin in T2DM Patients Starting Basal Insulin

NCT01871558 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus (T2DM)

Interventions

DRUG: Vildagliptin
DRUG: Metformin
DRUG: sulfonylurea (SU)
DRUG: Basal Insulin

Sponsor

Novartis Pharmaceuticals